Epidermal growth factor receptor (EGFR) mutations are found in 15–50% of non-small cell lung cancers (NSCLC), especially in women, non-smokers, Asians, and patients with adenocarcinoma [1, 2]. The gene discussed is EGFR; the disease is adenocarcinoma.